Ravinet, Aurelie <br/><br/>
Impact of Thymoglobulin by Stem Cell Source (Peripheral Blood Stem Cell or Bone Marrow) After Myeloablative Stem Cell Transplantation From HLA 10/10-Matched Unrelated Donors: A Report From the Société Française de Greffe de Moelle et de Thérapie Cellulaire.  [electronic resource] 

 -  Transplantation  Aug 2016 
 - 1732-9 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1534-6080 
<br/><br/><label>Standard No.: </label>10.1097/TP.0000000000000976  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antilymphocyte Serum--adverse effects<br/>Bone Marrow Transplantation--methods<br/>Busulfan--therapeutic use<br/>Chi-Square Distribution<br/>Chronic Disease<br/>Cyclophosphamide--therapeutic use<br/>Disease-Free Survival<br/>Dose Fractionation, Radiation<br/>Female<br/>France<br/>Graft vs Host Disease--immunology<br/>HLA Antigens--immunology<br/>Histocompatibility<br/>Histocompatibility Testing<br/>Humans<br/>Immunosuppressive Agents--adverse effects<br/>Kaplan-Meier Estimate<br/>Leukemia, Myeloid, Acute--diagnosis<br/>Male<br/>Middle Aged<br/>Multivariate Analysis<br/>Myeloablative Agonists--therapeutic use<br/>Myelodysplastic Syndromes--diagnosis<br/>Peripheral Blood Stem Cell Transplantation--adverse effects<br/>Proportional Hazards Models<br/>Recurrence<br/>Retrospective Studies<br/>Risk Factors<br/>Time Factors<br/>Transplantation Conditioning--adverse effects<br/>Treatment Outcome<br/>Unrelated Donors<br/>Whole-Body Irradiation<br/>Young Adult